| 1 |
Quantitative PET in the 2020s: a roadmap |
|
|
| Steven R Meikle,Vesna Sossi,Emilie Roncali,Simon R Cherry,Richard Banati,David Mankoff,Terry Jones,Michelle James,Julie Sutcliffe,Jinsong Ouyang,Yoann Petibon,Chao Ma,Georges El Fakhri,Suleman Surti,Joel S Karp,Ramsey D Badawi,Taiga Yamaya,Go Akamatsu,Georg Schramm,Ahmadreza Rezaei,Johan Nuyts,Roger Fulton,André Kyme,Cristina Lois,Hasan Sari,Julie Price,Ronald Boellaard,Robert Jeraj,Dale L Bailey,Enid Eslick,Kathy P Willowson,Joyita Dutta |
|
| Physics in Medicine & Biology. 2021; 66(6): 06RM01 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Radiopharmaceutical Chemistry and Drug Development—Whatćs Changed? |
|
|
| Charles A. Kunos,David A. Mankoff,Michael K. Schultz,Stephen A. Graves,Daniel A. Pryma |
|
| Seminars in Radiation Oncology. 2021; 31(1): 3 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases |
|
|
| René Fernández,Elisabeth Eppard,Wencke Lehnert,Luis David Jiménez-Franco,Cristian Soza-Ried,Matías Ceballos,Jessica Ribbeck,Andreas Kluge,Frank Rösch,Marian Meckel,Konstantin Zhernosekov,Vasko Kramer,Horacio Amaral |
|
| Journal of Nuclear Medicine. 2021; 62(8): 1126 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
B7-H3-targeted Radioimmunotherapy of Human Cancer |
|
|
| Benjamin B. Kasten,Soldano Ferrone,Kurt R. Zinn,Donald J. Buchsbaum |
|
| Current Medicinal Chemistry. 2020; 27(24): 4016 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer |
|
|
| Wen-Ting K Tsai,Kirstin A Zettlitz,Magnus Dahlbom,Robert E Reiter,Anna M Wu |
|
| Molecular Imaging and Biology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Prostate Cancer Theranostics - An Overview |
|
|
| Diane Abou,Nadia Benabdallah,Wen Jiang,Lu Peng,Hanwen Zhang,Alexandria Villmer,Mark S. Longtine,Daniel L. J. Thorek |
|
| Frontiers in Oncology. 2020; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403 |
|
|
| Xiaoxi Ling,Joseph D. Latoche,Cindy J. Choy,Brenda F. Kurland,Charles M. Laymon,Yijen Wu,Nathan Salamacha,Ding Shen,Jonathan J. Geruntho,Lora H. Rigatti,Hillarie P. Windish,Beatrice Langton-Webster,Clifford E. Berkman,Carolyn J. Anderson |
|
| Molecular Imaging and Biology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors |
|
|
| James Kelly,Alejandro Amor-Coarasa,Shashikanth Ponnala,Anastasia Nikolopoulou,Clarence Williams,David Schlyer,Yize Zhao,Dohyun Kim,John W. Babich |
|
| European Journal of Nuclear Medicine and Molecular Imaging. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application |
|
|
| Mark D. Bartholomä |
|
| Journal of Labelled Compounds and Radiopharmaceuticals. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry |
|
|
| Tiantian Li,Nien-Yun Wu,Na Song,Greta S. P. Mok |
|
| Annals of Nuclear Medicine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Nuclear Medicine Training: What Now? |
|
|
| David Mankoff,Daniel A. Pryma |
|
| Journal of Nuclear Medicine. 2017; 58(10): 1536 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Dosimetric analysis of 177Lu-DOTA-rituximab in patients with relapsed/refractory non-Hodgkin’s lymphoma |
|
|
| Madhav P. Yadav,Suhas Singla,Parul Thakral,Sanjana Ballal,Chandrasekhar Bal |
|
| Nuclear Medicine Communications. 2016; 37(7): 735 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
An automatic delineation method for bone marrow absorbed dose estimation in 89Zr PET/CT studies |
|
|
| N.E. Makris,R. Boellaard,C.W. Menke,A.A. Lammertsma,M.C. Huisman |
|
| EJNMMI Physics. 2016; 3(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Relevance of radiobiological concepts in radionuclide therapy of cancer |
|
|
| Chandan Kumar,Neena Shetake,Sejal Desai,Amit Kumar,Grace Samuel,Badri N. Pandey |
|
| International Journal of Radiation Biology. 2016; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model |
|
|
| Liang-Ting Lin,Chun-Yuan Chang,Chih-Hsien Chang,Hsin-Ell Wang,Shih-Hwa Chiou,Ren-Shyan Liu,Te-Wei Lee,Yi-Jang Lee |
|
| Oncotarget. 2016; 7(40): 65782 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization |
|
|
| Olufoladare G. Olorunsola,Maureen P. Kohi,Spencer C. Behr,Pallav K. Kolli,Andrew G. Taylor,Ricky T. Tong,Jeanne M. LaBerge,Robert K. Kerlan,Nicholas Fidelman |
|
| Journal of Vascular and Interventional Radiology. 2015; 26(10): 1472 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic |
|
|
| MARLEIN MIRANDA CONA,MICHEL KOOLE,YUANBO FENG,YEWEI LIU,ALFONS VERBRUGGEN,RAYMOND OYEN,YICHENG NI |
|
| International Journal of Oncology. 2014; 44(3): 819 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Characteristics of Primary and Secondary Hepatic Malignancies Associated with Hepatopulmonary Shunting |
|
|
| Ron C. Gaba,Sean P. Zivin,Mark S. Dikopf,Ahmad Parvinian,Leigh C. Casadaban,Yang Lu,James T. Bui |
|
| Radiology. 2014; : 131969 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications |
|
|
| Marlein Miranda Cona |
|
| World Journal of Methodology. 2013; 3(4): 45 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer |
|
|
| Chisato Yoshida,Atsushi B. Tsuji,Hitomi Sudo,Aya Sugyo,Tatsuya Kikuchi,Mitsuru Koizumi,Yasushi Arano,Tsuneo Saga,Javier S. Castresana |
|
| PLoS ONE. 2013; 8(3): e59248 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
The Role of p53 in Combination Radioimmunotherapy with 64Cu-DOTA-Cetuximab and Cisplatin in a Mouse Model of Colorectal Cancer |
|
|
| Yunjun Guo,Jesse J. Parry,Richard Laforest,Buck E. Rogers,Carolyn J. Anderson |
|
| Journal of Nuclear Medicine. 2013; 54(9): 1621 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
Users Online: 903 
